Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Equitable Holdings, formerly known as AXA Equitable, is a prominent American financial services company that operates primarily in the insurance and investment management sectors. The company provides a wide range of products including variable annuities, life insurance, and retirement plans, as well as asset management services through its subsidiary AllianceBernstein. While Equitable is a major provider of health-related insurance and employee benefits, it is not a biotechnology or pharmaceutical research and development firm. For a biotech analyst, the company is most relevant as a large-scale institutional investor in the healthcare sector and a provider of corporate financial solutions. The entity became an independent, publicly traded company following its spin-off from the French AXA Group in 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AXA Equitable.